Connect with us

Health

Covid booster jabs offered at NHS walk-in clinics in England

booster jabs

Covid booster jabs offered at NHS walk-in clinics in England

Covid booster jabs are now being given at walk-in clinics in England as the NHS aims to increase vaccine uptake before what is expected to be a challenging winter.

From Monday, anyone in an eligible group who had their second dose of a coronavirus vaccine at least six months ago can turn up at one of hundreds of sites to get their top-up without making an appointment. The walk-in centres are also offering vaccinations to 12- to 15-year-olds.

The move follows criticism of the booster campaign, with only about half of the 12 million people in England eligible so far for a third vaccine dose having received one. The vaccine rollout to teenagers has lagged behind that of countries including France, Italy and Spain.

People entitled to a booster jab are: those aged 50 and over, people who live and work in care homes; frontline health and social care workers; people aged 16 and over with a health condition that puts them at high risk of getting seriously ill from Covid-19; those aged 16 and over who are a main carer for someone at high risk from the virus, and; people aged 16 and over who live with someone who is more likely to get infections.

Nikki Kanani, a GP and the deputy lead for the NHS Covid-19 vaccination programme, said: “NHS staff are making it as easy as possible for people to get their top-up vaccination, and from today people can now go online, find their nearest site and go and get their booster without delay.

“The booster is not just nice to have. It is really important protection ahead of what we know will be a challenging winter.”

People are advised to use the NHS online walk-in finder to check where their nearest centre is and whether it is offering boosters, and vaccines for 12- to 15-year-olds. NHS England said almost everyone registered with a GP practice lives within 10 miles of a fixed vaccination site.

On Friday clinical guidelines were amended to allow care home residents and some vulnerable people to get their Covid booster vaccine a month early, in an effort to boost immunity during the winter.

The booster campaign is a central part of the government’s strategy for limiting hospital admissions because immunity from the initial two doses wanes over time, particularly in older adults and at-risk groups.

Protection against symptomatic illness falls from 65% up to three months after the second dose to 45% six months after the second dose for the Oxford/AstraZeneca vaccine and from 90% to 65% for the Pfizer/BioNTech vaccine, according to the latest evidence from the government’s scientific advisers. Protection against hospitalisation is estimated to fall from 95% to 75% for Oxford/AstraZeneca and from 99% to 90% for Pfizer/BioNTech.

On Sunday a further 38,009 people were reported as testing positive for Covid-19 in the UK in the previous 24 hours, with the seven-day total down 14% on the previous week, and 74 deaths were reported, with the seven-day total up 16%. A total of 45,697,856 second vaccine doses had been administered as of 30 October, whandile a combined total of 7,925,851 booster and third doses had been delivered, a day-on-day rise of 361,428.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

one × two =

Health

AIDS Agency Chief Says 1 Out Of 100 Persons Positive In Kaduna

The Executive Secretary of Kaduna State Aids Control Agency (KADSACA), Dr Isa Baka has said a survey had revealed that one out of 100 people is positive to the AIDS disease in the state.

Baka disclosed this speaking shortly after a walk in commemoration of the World AIDS Day, on Thursday in Kaduna.

The theme of the year’s’ World AIDS Day is “Equalise to End AIDS: Equal Access to Treatment and Prevention Services’’.

He said the present statistics was a remarkable development against previous survey which gave 11 of every 100 people in the state.

Baka added that the AIDS prevalence in Kaduna, which is at 1.1, being a survey carried out by the state government itself, was later done at the national level, where that of Kaduna was confirmed as very accurate.

“At the national level, the prevalence of the virus (AIDS) was at 1.4 (four people out of 100 test positive), while that of Kaduna is confirmed to be 1.1, was in determination of the state government and KADSACA’s efforts to ensure minimal prevalence of the virus,” he said.

He said as part of efforts to continue reducing the prevalence of AIDS in the state, government initiated programmes across the 23 LGAs.

He said one of the UNICEF anchored programmes, which is the ‘Adolescent and Youths Living With HIV and AIDS’ programme, was present and effective in at least, 18 LGAs and 24 sites in the state.

Continue Reading

Health

Malawi Commences Large Scale Malaria Vaccination- First In The World

Malawi has commenced large-scale vaccination of children against malaria.

This is the first large-scale malaria vaccination campaign since the World Health Organisation (WHO) endorsed the widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine in October 2021.

The endorsement followed a two-year vaccination programme, which involved more than 800,000 children in Ghana, Kenya and Malawi.

Recommended for children from five months of age to around 18 months, the vaccine  has an efficacy of 39 percent.

The first phase of the vaccination in Malawi is expected to cover 11 of the country’s 28 districts.

In a tweet on Tuesday, the WHO in Malawi said the expansion of access to the malaria vaccine will enable more children at risk of malaria to benefit from an additional prevention tool.

“Malawi has expanded access to the first malaria vaccine! The expansion of the RTS,S Malaria vaccine, into the 11 districts that participated in the malaria vaccine implementation program (MVIP) has been launched today. The vaccine offers a glimmer hope for Malawi,” WHO wrote.

Michael Kayange, Malawi’s national malaria control programme manager, told the BBC’s Focus on Africa that although the vaccine has low efficacy, “in malaria control, there is no single intervention that does it all”.

Continue Reading

Health

Nigeria Yet To Attain 70% Covid-19 Vaccination Coverage- NPHCDA

The National Primary Health Care Development Agency (NPHCDA) has disclosed that Nigeria is yet to achieve 70 percent coverage for COVID-19 vaccination.

Faisal Shuaib, executive director of NPHCDA, said on Tuesday that as of November 25, a total of 56,790,371 eligible persons targeted for COVID-19 vaccination are fully vaccinated while 12,492,646 are partially vaccinated in 36 states and the FCT.

“We are 21.6 million eligible persons away from reaching its target of fully vaccinating 70 percent of its eligible population by December 2022,” he said.

“But 62 percent of the country’s eligible population is at least partially vaccinated against COVID-19.

“The country has fully vaccinated half of the total population eligible for COVID-19 vaccination.

“We have also fully vaccinated an additional over 25 percent of its eligible population, in the last 110 days of SCALES 3.0 implementation.”

The executive director said 13.2 percent of fully vaccinated persons in the country have received the COVID-19 booster dose for additional protection against the virus.

He commended the COVID-19 strategy group for achieving 50 percent vaccination coverage in the country and promised that the momentum would be sustained.

Shuaib said he has also directed the team to intensify efforts toward the attainment of herd immunity.

“Until this is achieved, the strategy group will continue to develop strategies that will help the country achieve health security,” he said.

Continue Reading
Advertisement

Trending